•  
  •  
  •  
  •  

2026-07-22 04:41:24

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • CRISIL Limited Reports Q2 CY26 / Q1 FY27 Results: Consolidated Revenue Jumps 27.6% YoY to ₹1,075.39 Crore; Net Profit Reaches ₹216.46 Crore
  • Purple Finance Grants In-Principle Approval to Acquire 100% Stake in Saksham Gram Credit
  • InfoBeans Technologies Reports Q1 FY27 Results: Revenue Jumps 36.6% YoY to ₹152.77 Crore; Net Profit Stands at ₹21.62 Crore
  • Gamco Limited Reports Q1 FY27 Results: Consolidated Revenue Surges 105.8% YoY to ₹113.72 Crore; PAT Reaches ₹32.43 Crore
  • Gabriel India Reports Q1 FY27 Results: Consolidated Revenue Up 15.5% YoY to ₹1,425.68 Crore; Net Profit Reaches ₹108.13 Crore

Keywords Selected:  Injectables

Stock Report

  • Aptus Pharma Ltd to expand into life saving injectables and ICU care products
  • Caplin Point Laboratories Ltd's injectables facility completes INVIMA audit successfully
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Triamcinolone Acetonide Injectable Suspension USP, 40 mg/mL
  • Lupin receives U.S. FDA approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity
  • Zydus Lifesciences Ltd receives warning letter from USFDA for Jarod injectables manufacturing facility
  • Zydus Lifesciences Ltd receives OAI classification from USFDA for Jarod Injectables facility
  • Zydus Lifesciences Ltd receives 4 observations from USFDA post inspection at SEZ Onco Injectable site
  • Zydus receives EIR for the injectables manufacturing facility at Zydus Biotech Park, Ahmedabad
  • USFDA inspection at Zydus' injectables manufacturing facility at Zydus Biotech Park, concludes with Nil observations
  • Aurobindo announces signing of voluntary license with Medicines Patent Pool for Cabotegravir Long Acting Injectable for HIV pre-exposure prophylaxis for 90 countries including India
  • Zydus receives EIR from USFDA for its injectables manufacturing facility at Jarod
  • Zydus to supply Sagent's Caffeine Citrate Oral Solution from Jarod, post USFDA's PAS Approval
  • Kilitch Drugs Commences Rs. 100 Crore New Facility Expansion Plan
  • IPCA Laboratories Ltd to acquire majority stake in Lyka Labs Ltd
  • Zydus Cadila receives final approval from USFDA for Decitabine Injection

Latest Post

  • CRISIL Limited Reports Q2 CY26 / Q1 FY27 Results: Consolidated Revenue Jumps 27.6% YoY to ₹1,075.39 Crore; Net Profit Reaches ₹216.46 Crore
  • Purple Finance Grants In-Principle Approval to Acquire 100% Stake in Saksham Gram Credit
  • InfoBeans Technologies Reports Q1 FY27 Results: Revenue Jumps 36.6% YoY to ₹152.77 Crore; Net Profit Stands at ₹21.62 Crore
  • Gamco Limited Reports Q1 FY27 Results: Consolidated Revenue Surges 105.8% YoY to ₹113.72 Crore; PAT Reaches ₹32.43 Crore
  • Gabriel India Reports Q1 FY27 Results: Consolidated Revenue Up 15.5% YoY to ₹1,425.68 Crore; Net Profit Reaches ₹108.13 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025